Description  Claims  Drawing  Cited references 

EP1083232A1   [0009] 
WO03051401A2   [0010] 
WO2006008154A1   [0011] 
US7074596B   [0035] 
WO2008016473A   [0035] 
WO2008157688A   [0035] 
WO2009149253A   [0035] 
WO2011015347A   [0035] 
WO2013059475A   [0035] 
WO2008083949A   [0153] 
WO1995021251A   [0156] 
WO1995012673A   [0156] 
WO199521915A   [0156] 
WO2014127917A   [0161] 
WO02098443A   [0211]  [0211] 
WO2013143700A   [0244]  [0244]  [0244]  [0244]  [0245]  [0245]  [0245]  [0245]  [0246]  [0247]  [0249]  [0250]  [0255]  [0255]  [0256]  [0256]  [0260]  [0261]  [0262]  [0264]  [0264]  [0264]  [0265] 
WO2012019780A   [0270] 
WO03086280A   [0293] 
WO2009030481A   [0310] 
WO2012013326A   [0323]  [0510] 
WO2011026641A   [0330] 
WO2012116811A   [0330] 
WO2010037539A   [0339]  [0512] 
WO2012113513A   [0339] 
WO2014189805A   [0418] 
WO2008077592A1   [0508] 

RNA   [0034] 
Bioorg. Med. Chem.   [0035] 
Absorption, Circular Dichroism and ORD of Polypeptides   [0037] 
PNAS USA   [0040] 
Nucleic Acids Res.   [0040] 
Semin. Immunol.   [0060] 
Methods Enzymol.   [0060] 
Crit. Rev. Oncol. Hematol.   [0066] 
Cancer Therapy   [0066] 
Annu. Rev. Immunol.   [0082] 
Curr. Gene Ther.   [0088]  [0089] 
Cancer Res.   [0097] 
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009   [0107] 
Toxicol Pathol.   [0113]  [0114] 
Nat. Rev. Drug Discov.   [0115] 
N. Engl. J. Med.   [0120] 
Cell   [0122] 
Mol. Aspects Med.   [0124] 
Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines   [0128] 
Pharmacological modulation of beta-catenin and its applications in cancer therapy   [0142] 
The STING pathway and the T cell-inflamed tumor microenvironment   [0144] 
Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants   [0144] 
Immunol Rev.   [0146] 
J. Immunother.   [0156] 
Semin. Oncol.   [0158] 
J Clin Oncol.   [0162]  [0426] 
Clin Cancer Res.   [0162]  [0426] 
N Engl J Med.   [0162]  [0427] 
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer   [0184] 
Curr. Opin. Genet. Dev.   [0211] 
Proc. Natl. Acad. Sci. USA   [0211] 
EMBO J.   [0211] 
Development   [0233] 
Purification of PCR Products   [0233] 
Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses   [0292] 
Nature   [0293] 
Proc NatlAcadSci USA   [0293] 
Nature   [0348] 
Front Pharmacol.   [0365] 
Int J Nanomedicine   [0366] 
Adv Drug Deliv Rev.   [0367] 
Cancer Cell   [0414] 
Proc Natl Acad Sci USA   [0414] 
Cancer Res.   [0414] 
Nature   [0414] 
Cancer Res.   [0414] 
Oncogene   [0414] 
Bioorg Med Chem.   [0414] 
Nat Commun.   [0414] 
Nat Chem Biol.   [0414] 
Cell Res.   [0414] 
Proc Natl Acad Sci USA   [0414] 
Cancer Prev Res.   [0414]